Dexmedetomidine Reduces Ventilator-Induced Lung Injury (VILI) by Inhibiting Toll-Like Receptor 4 (TLR4) Nuclear Factor (NF)-κB Signaling Pathway. Biomol Biomed 2018, 18 (2), 162-169. https://doi.org/10.17305/bjbms.2018.2400.